Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working GroupClare Turnbull, Mark T.A. Donoghue, Sabrina Talukdar et al.|Annals of Oncology|2019Cited by 237
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsAngela George, Nazneen Rahman, Daniel Riddell et al.|Scientific Reports|2016Cited by 224
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Julie A. Vendrell, Frédérique Penault‐Llorca et al.|European Journal of Cancer|2021Cited by 174
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163
Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendationsZeid Kuzbari, Chaitanya Bandlamudi, Chey Loveday et al.|Annals of Oncology|2022Cited by 133